Oncological consequences of impaired immune surveillance against ubiquitous viruses

David T. Purtilo, James Linder

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The immune system is constantly challenged by ubiquitous viruses. Multiple immune defenses have evolved to meet these challenges, and thus immunocompetent individuals successfully respond to infection without sequela. X-linked lymphoproliferative syndrome patients, renal allograft recipients, and acquired immunodeficiency syndrome patients share impaired immune surveillance as a common feature. Such individuals are variously susceptible to numerous untoward complications following infection with Epstein-Barr virus, cytomegalovirus, herpes simplex virus, human papillomavirus, and hepatitis B virus. We hypothesize that failure of the immune system to control these viruses is instrumental in the occurrence of some B-cell lymphomas, Kaposi's sarcoma, and squamous-cell and hepatocellular carcinomas, Herein we review some mechanisms responsible for the breakdown of immune surveillance and the permissive role immunodeficiency plays in viral oncogenesis.

Original languageEnglish (US)
Pages (from-to)197-206
Number of pages10
JournalJournal of Clinical Immunology
Volume3
Issue number3
DOIs
StatePublished - Jul 1 1983

Fingerprint

Immune System
Viruses
Epstein-Barr Virus Infections
Lymphoproliferative Disorders
Kaposi's Sarcoma
B-Cell Lymphoma
Simplexvirus
Cytomegalovirus
Hepatitis B virus
Allografts
Hepatocellular Carcinoma
Squamous Cell Carcinoma
Carcinogenesis
Acquired Immunodeficiency Syndrome
Kidney
Infection

Keywords

  • Epstein-Barr virus
  • Immune surveillance
  • X-linked lymphoproliferative syndrome
  • acquired immune deficiency syndrome
  • cytomegalovirus
  • immunodeficiency
  • viral oncogenesis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Oncological consequences of impaired immune surveillance against ubiquitous viruses. / Purtilo, David T.; Linder, James.

In: Journal of Clinical Immunology, Vol. 3, No. 3, 01.07.1983, p. 197-206.

Research output: Contribution to journalArticle

@article{65b70318e1ce4265b4b9c22edb7b5e89,
title = "Oncological consequences of impaired immune surveillance against ubiquitous viruses",
abstract = "The immune system is constantly challenged by ubiquitous viruses. Multiple immune defenses have evolved to meet these challenges, and thus immunocompetent individuals successfully respond to infection without sequela. X-linked lymphoproliferative syndrome patients, renal allograft recipients, and acquired immunodeficiency syndrome patients share impaired immune surveillance as a common feature. Such individuals are variously susceptible to numerous untoward complications following infection with Epstein-Barr virus, cytomegalovirus, herpes simplex virus, human papillomavirus, and hepatitis B virus. We hypothesize that failure of the immune system to control these viruses is instrumental in the occurrence of some B-cell lymphomas, Kaposi's sarcoma, and squamous-cell and hepatocellular carcinomas, Herein we review some mechanisms responsible for the breakdown of immune surveillance and the permissive role immunodeficiency plays in viral oncogenesis.",
keywords = "Epstein-Barr virus, Immune surveillance, X-linked lymphoproliferative syndrome, acquired immune deficiency syndrome, cytomegalovirus, immunodeficiency, viral oncogenesis",
author = "Purtilo, {David T.} and James Linder",
year = "1983",
month = "7",
day = "1",
doi = "10.1007/BF00915343",
language = "English (US)",
volume = "3",
pages = "197--206",
journal = "Journal of Clinical Immunology",
issn = "0271-9142",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Oncological consequences of impaired immune surveillance against ubiquitous viruses

AU - Purtilo, David T.

AU - Linder, James

PY - 1983/7/1

Y1 - 1983/7/1

N2 - The immune system is constantly challenged by ubiquitous viruses. Multiple immune defenses have evolved to meet these challenges, and thus immunocompetent individuals successfully respond to infection without sequela. X-linked lymphoproliferative syndrome patients, renal allograft recipients, and acquired immunodeficiency syndrome patients share impaired immune surveillance as a common feature. Such individuals are variously susceptible to numerous untoward complications following infection with Epstein-Barr virus, cytomegalovirus, herpes simplex virus, human papillomavirus, and hepatitis B virus. We hypothesize that failure of the immune system to control these viruses is instrumental in the occurrence of some B-cell lymphomas, Kaposi's sarcoma, and squamous-cell and hepatocellular carcinomas, Herein we review some mechanisms responsible for the breakdown of immune surveillance and the permissive role immunodeficiency plays in viral oncogenesis.

AB - The immune system is constantly challenged by ubiquitous viruses. Multiple immune defenses have evolved to meet these challenges, and thus immunocompetent individuals successfully respond to infection without sequela. X-linked lymphoproliferative syndrome patients, renal allograft recipients, and acquired immunodeficiency syndrome patients share impaired immune surveillance as a common feature. Such individuals are variously susceptible to numerous untoward complications following infection with Epstein-Barr virus, cytomegalovirus, herpes simplex virus, human papillomavirus, and hepatitis B virus. We hypothesize that failure of the immune system to control these viruses is instrumental in the occurrence of some B-cell lymphomas, Kaposi's sarcoma, and squamous-cell and hepatocellular carcinomas, Herein we review some mechanisms responsible for the breakdown of immune surveillance and the permissive role immunodeficiency plays in viral oncogenesis.

KW - Epstein-Barr virus

KW - Immune surveillance

KW - X-linked lymphoproliferative syndrome

KW - acquired immune deficiency syndrome

KW - cytomegalovirus

KW - immunodeficiency

KW - viral oncogenesis

UR - http://www.scopus.com/inward/record.url?scp=0020525875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020525875&partnerID=8YFLogxK

U2 - 10.1007/BF00915343

DO - 10.1007/BF00915343

M3 - Article

VL - 3

SP - 197

EP - 206

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

SN - 0271-9142

IS - 3

ER -